Susquehanna International Group’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-29,134
| Closed | -$223K | – | 11371 |
|
|
2020
Q1 | $180K | Buy |
+29,134
| New | +$257K | ﹤0.01% | 8815 |
|
|
2019
Q4 | – | Sell |
-31,950
| Closed | -$349K | – | 11079 |
|
|
2019
Q3 | $369K | Sell |
31,950
-134,983
| -81% | -$1.42M | ﹤0.01% | 7882 |
|
|
2019
Q2 | $1.67M | Buy |
+166,933
| New | +$1.8M | ﹤0.01% | 4535 |
|
|
2017
Q4 | – | Sell |
-154,814
| Closed | -$2.33M | – | 10184 |
|
|
2017
Q3 | $2.86M | Sell |
154,814
-10,700
| -6% | -$199K | ﹤0.01% | 3303 |
|
|
2017
Q2 | $3.05M | Buy |
165,514
+10,700
| +7% | +$212K | ﹤0.01% | 3119 |
|
|
2017
Q1 | $3.49M | Buy |
154,814
+74,890
| +94% | +$1.79M | ﹤0.01% | 2802 |
|
|
2016
Q4 | $2.78M | Sell |
79,924
-320,616
| -80% | -$9.58M | ﹤0.01% | 3396 |
|
|
2016
Q3 | $9.82M | Buy |
400,540
+150,452
| +60% | +$3.76M | ﹤0.01% | 1556 |
|
|
2016
Q2 | $5.98M | Buy |
250,088
+130,387
| +109% | +$2.99M | ﹤0.01% | 1985 |
|
|
2016
Q1 | $2.8M | Sell |
119,701
-84,444
| -41% | -$2M | ﹤0.01% | 3164 |
|
|
2015
Q4 | $6.16M | Buy |
204,145
+63,087
| +45% | +$2.04M | ﹤0.01% | 2261 |
|
|
2015
Q3 | $5.61M | Sell |
141,058
-167,306
| -54% | -$10.4M | ﹤0.01% | 2511 |
|
|
2015
Q2 | $21.3M | Buy |
308,364
+61,325
| +25% | +$3.86M | 0.01% | 1254 |
|
|
2015
Q1 | $13.5M | Buy |
247,039
+223,384
| +944% | +$10.6M | 0.01% | 1579 |
|
|
2014
Q4 | $1.01M | Buy |
+23,655
| New | +$855K | ﹤0.01% | 5874 |
|
|
2014
Q3 | – | Sell |
-18,680
| Closed | -$398K | – | 10170 |
|
|
2014
Q2 | $387K | Buy |
+18,680
| New | +$345K | ﹤0.01% | 7947 |
|
Susquehanna International Group's AMAG Position: Q2 2020 in Review
Susquehanna International Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 29,134 shares — an estimated $223K sold.
Susquehanna International Group first reported a position in AMAG in Q2 2014 and held it in 16 quarters. The position peaked at $21.3M in Q2 2015. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.
- Susquehanna International Group reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Susquehanna International Group sold 29,134 AMAG Pharmaceuticals shares in Q2 2020, an estimated $223K.
- Susquehanna International Group first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 16 quarters.
- Susquehanna International Group's AMAG Pharmaceuticals position peaked at $21.3M in Q2 2015.
- 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.